These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9194899)

  • 1. p53 accumulation and apoptosis in embolized meningiomas.
    Nakasu S; Nakajima M; Nakazawa T; Nakasu Y; Handa J
    Acta Neuropathol; 1997 Jun; 93(6):599-605. PubMed ID: 9194899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of bcl-2 and bax expression in embolized meningiomas.
    Nakasu S; Nakajima M; Nakazawa T; Nakasu Y; Handa J
    Brain Tumor Pathol; 1998; 15(1):13-7. PubMed ID: 9879458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrosis and apoptosis of tumor cells in embolized meningiomas: histopathology and P53, BCL-2, CD-68 immunohistochemistry.
    Matyja E; Taraszewska A; Marszałek P
    Folia Neuropathol; 1999; 37(2):93-8. PubMed ID: 10464427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.
    Karamitopoulou E; Perentes E; Tolnay M; Probst A
    Hum Pathol; 1998 Feb; 29(2):140-5. PubMed ID: 9490273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 overexpression and proliferative potential in malignant meningiomas.
    Nagashima G; Aoyagi M; Yamamoto M; Yamamoto S; Wakimoto H; Ohno K; Yamamoto K; Hirakawa K
    Acta Neurochir (Wien); 1999; 141(1):53-61; discussion 60-1. PubMed ID: 10071687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells.
    Shenberger JS; Dixon PS
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):395-402. PubMed ID: 10460757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.
    Mercado-Pimentel ME; Miller C; Rolph DN; Villalobos EF; Dunn AM; Mohan PM; Igarashi S; Liu X; Yrun-Duffy M; Patel NK; Read CM; Francis RH; Lane AI; Murugesh S; Jacob A
    Otol Neurotol; 2017 Jan; 38(1):139-146. PubMed ID: 27755359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence.
    Hakin-Smith V; Battersby RD; Maltby EL; Timperley WR; Royds JA
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):40-9. PubMed ID: 11299001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.
    Konstantinidou A; Korkolopoulou P; Patsouris E; Mahera H; Hranioti S; Kotsiakis X; Davaris P
    J Neurooncol; 2001 Oct; 55(1):1-9. PubMed ID: 11804277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histological features of multiple meningiomas compared with solitary meningiomas.
    Huang H; Buhl R; Hugo HH; Mehdorn HM
    Neurol Res; 2005 Apr; 27(3):324-32. PubMed ID: 15845217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas].
    Miyagami M; Kanou T; Nakamura S
    No To Shinkei; 1996 Aug; 48(8):719-25. PubMed ID: 8797205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells.
    Al-Khalaf HH; Lach B; Allam A; AlKhani A; Alrokayan SA; Aboussekhra A
    J Neurooncol; 2007 May; 83(1):9-15. PubMed ID: 17245624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study.
    Ng HK; Chen L
    Histopathology; 1998 Jul; 33(1):64-70. PubMed ID: 9726051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and its regulation in flat-type early colorectal carcinoma: comparison with that in polypoid-type early colorectal carcinoma.
    Ozawa A; Konishi F; Fukayama M; Kanazawa K
    Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S23-8. PubMed ID: 11052474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.